* BIMATOPROST
Lumigan Drug Information
The drug is a synthetic prostamide analog with ocular hypotensive activity used to reduce severe intraocular hypertension owing to glaucoma or other eye diseases. The drug helps to prevent blindness or visual loss by treating eye pressure. The result is manifested approximately 4 hours after administration and significant pressure reduction is observed 8 - 12 hours later. Lumigan may be used concomitantly with other topical ophthalmic drugs to lower intraocular pressure. If other ophthalmic medications are prescribed simultaneously, it is important to administer them at least five minutes apart.
Lumigan 0.03 Dosage Information
The eye solution should be administered in the evening daily, in the dosage prescribed by your eye specialist. For cases of glaucoma affected eyes, one drop of Lumigan 0.03% should be administered. The dosage should be administered in the conjuctival sac; slightly closing the eyelid helps to lower the chance of systemic side effects. More frequent administration than once daily may decrease the effect of lowering the intraocular pressure. At North Meds, the available dosages of generic drug are 0.01% and 0.03%, and brand Lumigan is available in 0.01% and 0.03% as well. Buy cheap Lumigan from North Meds.
Side Effects and Precautions for Lumigan 0.03
Side effects include headaches, eye irritation eyes, itching in the eyes, swelling and weakness. Serious effects of Bimatoprost are cataract, blurred vision, severe eye pain, eye discharge and respiratory infections. If patients experience any of the above side effects with discount Lumigan, they should contact their doctor immediately. Bimatoprost should be avoided by patients allergic to hydrochloric acid, sodium chloride or benzalkonium chloride. With pregnant or breast feeding women, consultation with their doctor is recommended before they buy Lumigan to use for treatment. Usage of this medicine may also cause eyelashes growth and permanent changes to periorbital tissue and iris pigmentation.
* All trademarks and registered trademarks are the property of their respective owners.
